10 Biotech Stocks Expected to at Least Double

Description:

According to Jake Lynch, "Investing in biotechnology stocks is a tricky game. Many biotech companies are unprofitable and burn through cash, appearing destined for shareholder dilution or bankruptcy court. Yet, those that do succeed deliver obscene returns. ... Here are 10 of the highest-rated biotech stocks. They're exceptionally risky, but are predicted by analysts to double, triple, quadruple or even quintuple in the next 12 months." Read more here.

>>Also: 10 Pharma Stocks With Up to 88% Upside

Most Viewed Portfolios

View All

Articles

Hedge Funds Love These 5 Health Care Stocks -- but Should You?

04.23.14 | 12:59 PM

BALTIMORE (Stockpickr) -- The health care sector got a shot in the arm yesterday, buoyed by big M&A deals at a half dozen multi-billion drug stocks...

5 Stocks With Big Insider Buying

04.23.14 | 12:27 PM

DELAFIELD, Wis. (Stockpickr) -- Corporate insiders sell their own companies' stock for a number of reasons. >>5 Stocks Set to Soar on Bullish Ear...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter